| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1465-3362.2009.00132.X |
| P698 | PubMed publication ID | 20565524 |
| P50 | author | Marina Davoli | Q28037107 |
| Laura Amato | Q28037108 | ||
| Anna Maria Bargagli | Q42606073 | ||
| P2093 | author name string | Simona Vecchi | |
| Silvia Minozzi | |||
| Carlo A Perucci | |||
| P2860 | cites work | Adolescent risk factors and the prediction of persistent alcohol and drug use into adulthood. | Q52193277 |
| P433 | issue | 3 | |
| P921 | main subject | systematic review | Q1504425 |
| psychosis | Q170082 | ||
| P304 | page(s) | 304-317 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | Drug and Alcohol Review | Q15760162 |
| P1476 | title | An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results | |
| P478 | volume | 29 |
| Q47335048 | Anxiety sensitivity and cannabis use-related problems: The impact of race. |
| Q28650412 | Associations of cannabis and cigarette use with psychotic experiences at age 18: findings from the Avon Longitudinal Study of Parents and Children |
| Q39131734 | Building smart cannabis policy from the science up. |
| Q36157669 | Cannabinoids and Schizophrenia: Risks and Therapeutic Potential |
| Q92312460 | Cannabis and psychosis: revisiting a nineteenth century study of 'Indian Hemp and Insanity' in Colonial British India |
| Q38170165 | Cochrane systematic reviews in the field of addiction: past and future |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q35229933 | Comorbid substance use disorders in schizophrenia: a latent class approach |
| Q49351875 | Demographic and socioenvironmental predictors of premorbid marijuana use among patients with first-episode psychosis. |
| Q40266004 | Evidence that the presence of psychosis in non-psychotic disorder is environment-dependent and mediated by severity of non-psychotic psychopathology. |
| Q26865311 | Gone to Pot - A Review of the Association between Cannabis and Psychosis |
| Q30371361 | Habituation of the startle reflex depends on attention in cannabis users. |
| Q95488082 | High-potency cannabis and incident psychosis: correcting the causal assumption |
| Q33762566 | Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations |
| Q41234430 | Marijuana Use and Perceptions of Risk and Harm: A Survey among Canadians in 2016. |
| Q38365218 | Marijuana: a time-honored but untested treatment for epilepsy |
| Q37027187 | Overlapping meta-analyses on the same topic: survey of published studies |
| Q24187250 | Pharmacotherapies for cannabis dependence |
| Q61440575 | Pharmacotherapies for cannabis dependence |
| Q24235117 | Pharmacotherapies for cannabis withdrawal |
| Q38791674 | Psychosis and Substance Use: Implications for Conditional Release Readiness Evaluations |
| Q37015383 | Psychosis as a transdiagnostic and extended phenotype in the general population. |
| Q50774375 | Societal participation: examining the impact of a rehabilitation approach for young people with schizophrenia. |
| Q92897570 | Substance Use Disorders and Schizophrenia |
| Q55361377 | Substance use among outdoor treatment-seeking patients with mental illness: A case–control study from a tertiary care hospital of northern India. |
| Q34809059 | The association between cannabis abuse and subsequent schizophrenia: a Swedish national co-relative control study |
| Q40283819 | The burden of disease attributable to cannabis use in Canada in 2012. |
| Q24601890 | The endocannabinoid system, cannabinoids, and pain |
| Q39958490 | The environment and schizophrenia |
| Q34326515 | The pharmacologic and clinical effects of medical cannabis. |
Search more.